Related Experiment Video
Updated: Dec 24, 2025

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Functionalized carbon nanotubes as transporters for antisense oligodeoxynucleotides
Anika Kaufmann1, David Kunhardt, Giuseppe Cirillo
1Chair of Biochemistry, Department of Chemistry, Technische Universität Dresden, Bergstraße 66, D-01069 Dresden, Germany. Anika.Kaufmann@chemie.tu-dresden.de.
Functionalized multiwalled carbon nanotubes (MWCNT-f-OH) show improved stability for DNA delivery. These nanomaterials efficiently carry and release antisense oligodeoxynucleotides (AS-ODNs) into cancer cells with minimal toxicity.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Molecular Biology
Background:
- Efficient DNA delivery systems are crucial for DNA-based therapeutics.
- Multiwalled carbon nanotubes (MWCNTs) offer potential as nanocarriers.
- Functionalization is key to improving MWCNT properties for biological applications.
Purpose of the Study:
- To develop and evaluate hydroxyl-functionalized MWCNTs (MWCNT-f-OH) as a carrier for DNA therapeutics.
- To assess the stability, DNA adsorption, and release capabilities of MWCNT-f-OH.
- To investigate the biocompatibility and cellular uptake of MWCNT-f-OH.
Main Methods:
- Synthesis of MWCNT-f-OH via 1,3-dipolar cycloaddition.
- Adsorption of carrier strand oligodeoxynucleotides (CS-ODNs) and hybridization with antisense oligodeoxynucleotides (AS-ODNs).
- Radionuclide labeling for quantifying ODN adsorption and release; cell viability assays (EJ28 cell line); cellular uptake studies.
Main Results:
- MWCNT-f-OH exhibited enhanced stability in aqueous dispersions.
- Successful adsorption and hybridization of AS-ODNs onto MWCNT-f-OH.
- AS-ODNs were released at 80 °C and under physiological conditions (pH 37 °C).
- MWCNT-f-OH showed minimal cytotoxicity to EJ28 bladder carcinoma cells and were internalized by them.
Conclusions:
- MWCNT-f-OH is a stable and effective nanocarrier for AS-ODNs.
- The developed system demonstrates controlled release of therapeutic DNA.
- MWCNT-f-OH holds promise for advancing DNA-based cancer therapeutics.
More Related Videos
08:53Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
Published on: April 16, 2019
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024